Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study.
Maria Juncal-RuizLaura Riesco-DavilaJavier Váquez-BourgonVictor Ortiz García de la FozJacqueline Mayoral-van SonRosa Ayesa-ArriolaEsther Setién-SueroJuan Carlos LezaMarcos López HoyosBenedicto Crespo-FacorroPublished in: International journal of molecular sciences (2020)
Toll-like receptors (TLRs) are a pivotal component of the innate immune system that seem to have a role in the pathogenesis of psychosis. The purpose of this work was to compare the expression and functionality of 9 TLRs in three peripheral blood mononuclear cells (PBMCs) (monocytes, B cells, and T cells) between 33 drug-naïve first-episode psychosis (FEP) individuals and 26 healthy volunteers, at baseline and after 3-month of antipsychotic treatment. The expression of TLRs 1-9 were assessed by flow cytometry. For the assessment of the TLR functionality, cells collected in sodium heparin tubes were polyclonally stimulated for 18 h, with different agonists for human TLR1-9. The results of our study highlight the role that TLR5 and TLR8 might play in the pathophysiology of psychosis. We found a lower expression of these receptors in FEP individuals, regarding healthy volunteers at baseline and after 3-month of treatment on the three PBMCs subsets. Most TLRs showed a lower functionality (especially reduced intracellular levels of TNF-α) in patients than in healthy volunteers. These results, together with previous evidence, suggest that individuals with psychosis might show a pattern of TLR expression that differs from that of healthy volunteers, which could vary according to the intensity of immune/inflammatory response.
Keyphrases
- inflammatory response
- poor prognosis
- immune response
- toll like receptor
- rheumatoid arthritis
- emergency department
- lps induced
- long non coding rna
- endothelial cells
- nuclear factor
- bipolar disorder
- ejection fraction
- cell death
- oxidative stress
- peripheral blood
- prognostic factors
- signaling pathway
- newly diagnosed
- high intensity
- combination therapy
- smoking cessation
- clinical evaluation